Reports for TENOFOVIR DISOPROXIL FUMARATE

Ingredient

TENOFOVIR DISOPROXIL FUMARATE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MYLAN-TENOFOVIR DISOPROXIL 300MG TABLET Avoided shortage 2020-05-26 2020-06-03 115765
MYLAN-TENOFOVIR DISOPROXIL 300MG TABLET Avoided shortage 2022-12-08 2023-02-06 177336
TEVA-TENOFOVIR 300MG TABLET Resolved 2020-07-30 2020-12-17 121509
TEVA-TENOFOVIR 300MG TABLET Resolved 2022-02-17 2022-12-15 155186
PMS-TENOFOVIR 300MG TABLET Actual shortage 2024-05-10 2024-05-10 227785
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 600MG 200MG 300MG TABLET Avoided shortage 2020-04-29 2020-07-09 113424
TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR 600MG 200MG 300MG TABLET Resolved 2020-04-16 2020-05-08 112370
AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 600MG 200MG 300MG TABLET Avoided shortage 2020-12-07 2021-02-03 129766
AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 600MG 200MG 300MG TABLET Resolved 2021-04-12 2021-06-03 137370
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 600MG 300MG 200MG TABLET Resolved 2018-04-27 2019-06-19 47356

Showing 31 to 40 of 42

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ATRIPLA 300MG 200MG 600MG TABLET Discontinued 2021-08-17 2022-01-01 144260

Showing 1 to 1 of 1